NAII

Natural Alternatives International, Inc. is a formulator, manufacturer and marketer of nutritional supplements. Its primary business activity is to provide private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbs, and other nutritional supplements, as well as other health care products, to consumers both within and outside the United States. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer ecommerce channels, and retail stores. It manufactures products in a variety of forms, including capsules, tablets, chewable wafers, and powders to accommodate a variety of its customer’s preferences. It also seeks to commercialize its patent and trademarks through the direct distribution and sale of CarnoSyn, SR CarnoSyn, TriBsyn, new contract manufacturing opportunities, and various license, royalty, and similar arrangements.

Wall Street analysts forecast NAII stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for NAII is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Natural Alternatives International Inc revenue for the last quarter amounts to 37.73M USD, increased 13.82 % YoY.

Natural Alternatives International Inc. EPS for the last quarter amounts to -0.05 USD, decreased -84.85 % YoY.

Natural Alternatives International Inc (NAII) has 293 emplpoyees as of December 15 2025.

Today NAII has the market capitalization of 19.46M USD.